{"nctId":"NCT00345839","briefTitle":"E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events","startDateStruct":{"date":"2006-08-22","type":"ACTUAL"},"conditions":["Secondary Hyperparathyroidism","Chronic Kidney Disease"],"count":3883,"armGroups":[{"label":"Cinacalcet","type":"EXPERIMENTAL","interventionNames":["Drug: Cinacalcet"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Cinacalcet","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Inclusion:≥ 18 years of age\n* Treated with maintenance hemodialysis - PTH ≥ 300 pg/mL (31.8 pmol/L)\n* serum calcium ≥ 8.4mg/dL (2.1 mmol/L)\n* Ca x P ≥ 45 mg2\\*/dL2 (3.63 mmol2/L2)\n\nExclusion Criteria: - Exclusion:\n\n* Parathyroidectomy in the 12 weeks before the date of informed consent\n* Received therapy with cinacalcet within 3 months of randomization\n* Hospitalization within 12 weeks of randomization for any of the following events: a. Myocardial ischemia b. Unstable angina c. Heart Failure (HF) (including any unplanned presentation to a health care facility that would require mechanical intervention \\[i.e., unplanned dialysis treatment\\]) d. Peripheral vascular disease (other than dialysis vascular access revision) e. Stroke\n* History of seizure within 12 weeks prior to randomization\n* Scheduled date for kidney transplant from a known living donor\n* Anticipated parathyroidectomy within 6 months after randomization\n\n  * in all instances, the 2 refers to squared.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time to Primary Composite Endpoint (All-cause Mortality, Myocardial Infarction, Hospitalization for Unstable Angina, Heart Failure or Peripheral Vascular Event)","description":"Time to Primary Composite Endpoint (All-cause Mortality, Myocardial Infarction, Hospitalization for Unstable Angina, Heart Failure or Peripheral Vascular Event). Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55.0","spread":null},{"groupId":"OG001","value":"53.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to All-cause Mortality","description":"Time to All-cause Mortality. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Myocardial Infarction","description":"Time to Myocardial Infarction. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Hospitalization for Unstable Angina","description":"Time to Hospitalization for Unstable Angina. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Heart Failure","description":"Time to Heart Failure. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Peripheral Vascular Event","description":"Time to Peripheral Vascular Event. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Cardiovascular Mortality","description":"Time to Cardiovascular Mortality. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Stroke","description":"Time to Stroke. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Bone Fracture","description":"Time to Bone Fracture. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Parathyroidectomy","description":"Time to Parathyroidectomy. Stratified by history of diabetes and country.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1351,"n":1923},"commonTop":["Nausea","Vomiting","Diarrhoea","Dyspnoea","Cough"]}}}